Secondary prevention in non-valvular atrial fibrillation patients: a practical approach with edoxaban.

about

Secondary prevention in non-valvular atrial fibrillation patients: a practical approach with edoxaban.

Item

http://www.wikidata.org/entity/Q38944344

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Secondary prevention in non-va ...... ctical approach with edoxaban.

@en

type

Item

label

Secondary prevention in non-va ...... ctical approach with edoxaban.

@en

prefLabel

Secondary prevention in non-va ...... ctical approach with edoxaban.

@en

P1476

Secondary prevention in non-va ...... ctical approach with edoxaban.

@en

P2093

Alicia DeFelipe

http://www.w3.org/2001/XMLSchema#string

Jaime Masjuan

http://www.w3.org/2001/XMLSchema#string

P2860

New oral anticoagulants are not superior to warfarin in secondary prevention of stroke or transient ischemic attacks, but lower the risk of intracranial bleeding: insights from a meta-analysis and indirect treatment comparisons

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

Novel antidotes for target specific oral anticoagulants

Target-specific Oral Anticoagulants in the Emergency Department

Independent predictors of stroke in patients with atrial fibrillation: a systematic review

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

Edoxaban versus warfarin in patients with atrial fibrillation

Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial.

Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke registry.

P304

716-725

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/00207454.2016.1232256

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

127

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27586690

http://www.w3.org/2001/XMLSchema#string